Cash Flow from Operating Activities: A company's cash flows from operations.
Cadrenal Therapeutics, Inc. (CVKD) had Cash Flow from Operating Activities of $-5.24M for the most recently reported fiscal quarter, ending 2026-06-30.
| Income Statement Financials | |
-- |
|
$-3.32M |
|
-- |
|
-- |
|
$3.34M |
|
$-3.34M |
|
$0.02M |
|
$-3.32M |
|
$-3.32M |
|
$-3.32M |
|
$-3.32M |
|
$-3.32M |
|
$-3.32M |
|
$-3.34M |
|
$-3.34M |
|
2.91M |
|
2.91M |
|
$-1.14 |
|
$-1.14 |
|
| Balance Sheet Financials | |
$5.58M |
|
$0.00M |
|
$0.00M |
|
$5.59M |
|
$1.50M |
|
-- |
|
-- |
|
$1.50M |
|
$4.09M |
|
$4.09M |
|
$4.09M |
|
3.10M |
|
| Cash Flow Statement Financials | |
|
Cash Flow from Operating Activities |
$-5.24M |
$0.00M |
|
$3.61M |
|
$4.01M |
|
$2.39M |
|
$-1.62M |
|
$0.92M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
3.73 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-5.23M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-81.20% |
|
-81.20% |
|
-59.45% |
|
-81.20% |
|
$1.32 |
|
$-1.80 |
|
$-1.80 |
|